Allopurinol-Induced Uncommon Dermatological Emergency of Toxic Epidermal Necrolysis (TEN)

被引:2
|
作者
Pabani, Umesh Kumar [1 ]
Khan, Zahid [2 ,3 ,4 ,5 ]
Ali, Layla [6 ]
Shah, Shuheda K. [7 ]
Khan, Jebriel Ali [8 ]
机构
[1] Mid & South Essex NHS Fdn Trust, Internal Med, Southend On Sea, England
[2] Mid & South Essex NHS Fdn Trust, Acute Med, Southend On Sea, England
[3] Barts Heart Ctr, Cardiol, London, England
[4] Havering & Redbridge Univ Hosp NHS Trust, Cardiol & Gen Med, London, England
[5] Royal Free Hosp, Cardiol, London, England
[6] Southend Univ Hosp, Internal Med, Southend On Sea, England
[7] Mid & South Essex NHS Fdn Trust, Gen Med, Southend On Sea, England
[8] Great Western Hosp, Resp Med, Swindon, England
关键词
allopurinol-induced ten; drug-induced ten; medication-induced ten; antibiotics cream; severe cutaneous adverse drug reactions; adverse cutaneous drug reaction; cutaneous adverse drug reaction; systemic steroids; toxic epidermal necrolysis (ten); STEVENS-JOHNSON-SYNDROME;
D O I
10.7759/cureus.44812
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Toxic epidermal necrolysis (TEN) is a life-threatening, blistering dermatitis. It is characterized by fever and the development of mucocutaneous lesions, which lead to necrosis and sloughing of the epidermis. It is commonly triggered by medications and infections. We present the case of a 75-year-old male who presented to the hospital with a fever and widespread exfoliating skin rash involving 41% of his body surface area (BSA). He has a past medical history of gout, hypertension, asthma, and depression. He was recently started on allopurinol by his general practitioner (GP) for hyperuricemia. The condition also involved oral, eye, and pharynx mucosae. He was diagnosed with toxic epidermal necrolysis and was managed with intravenous (IV) hydrocortisone, steroid and antibiotic eye drops, and steroid and antibiotic topical creams. Due to the weak available evidence supporting the use of ciclosporin and intravenous immunoglobulins, this patient was managed with steroid use only. His rash initially worsened, but ultimately, he made a full recovery without any sequelae. The patient was reviewed in the dermatology clinic four weeks post -discharge, and he did not have any residual disease.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] ALLOPURINOL-INDUCED TOXIC EPIDERMAL NECROLYSIS
    DAN, M
    JEDWAB, M
    PELED, M
    SHIBOLET, S
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1984, 23 (02) : 142 - 144
  • [2] Allopurinol-Induced Toxic Epidermal Necrolysis
    Perdigao, Sofia
    Alves, Ana Sofia
    Nunes, Mariana
    Sousa, Cristiana
    Barros, Nelson
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [3] Allopurinol-Induced Overlapping Dress and Toxic Epidermal Necrolysis
    Fathallah, N.
    Mokni, S.
    Ouni, B.
    Ben Saida, I.
    Larif, S.
    Ghariani, N.
    Slim, R.
    Ben Salem, C.
    DRUG SAFETY, 2018, 41 (11) : 1188 - 1189
  • [4] Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis
    Lee, Haur Yueh
    Pang, Shiu Ming
    Thamotharampillai, Thirumoorthy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (02) : 352 - 353
  • [5] TOXIC EPIDERMAL NECROLYSIS - A DERMATOLOGICAL EMERGENCY
    MORAN, J
    ANAESTHESIA AND INTENSIVE CARE, 1981, 9 (02) : 185 - 185
  • [6] Allopurinol-induced toxic epidermal necrolysis featuring almost 60% skin detachment
    Wang, Feifei
    Ma, Zhuo
    Wu, Xinan
    Liu, Lihong
    MEDICINE, 2019, 98 (25)
  • [7] Allopurinol-induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis overlap syndrome
    Almeida, Paulo
    Pinto, Joel
    GALICIA CLINICA, 2021, 82 (01): : 57 - 57
  • [8] ASYMPTOMATIC HYPERURICEMIA AND ALLOPURINOL INDUCED TOXIC EPIDERMAL NECROLYSIS
    RENWICK, IGH
    BRITISH MEDICAL JOURNAL, 1985, 291 (6493): : 485 - 485
  • [9] A Case Report on Allopurinol Induced Toxic Epidermal Necrolysis
    Ushabhayi, C.
    Ajitha, K. N.
    Anuradha, M.
    Jeeja, M. C.
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S254 - S254
  • [10] A response letter to allopurinol-induced toxic epidermal necrolysis and association with HLA-B*5801 in White patients
    Yan, Dewen
    Zhang, Youming
    PHARMACOGENETICS AND GENOMICS, 2018, 28 (12): : 268 - 269